Hyderabad's Bharat Biotech's intranasal Covid vaccine approved for heterologous booster dose

iNCOVACC has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery that enables mass immunization to...

By Newsmeter Network  Published on 28 Nov 2022 1:25 PM GMT